Fundraising FoxHyrax Biosciences (Pty) Ltd
1 known investors
Find your way into Hyrax Biosciences (Pty) Ltd
Sign up to see every warm intro you have to Hyrax Biosciences (Pty) Ltd
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hyrax Biosciences (Pty) Ltd team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hyrax Biosciences develops Exatype, a DNA sequence analysis software platform that performs genotyping, quality control, reference mapping, and mutation calling for pathogens including HIV, TB, SARS-CoV-2, and cancer. It serves assay and instrument manufacturers, laboratories, pharmaceutical companies, clinical trial organizations, and research institutions.
Investors · 1
Frequently asked questions
- What does Hyrax Biosciences (Pty) Ltd do?
- Hyrax Biosciences develops Exatype, a DNA sequence analysis software platform that performs genotyping, quality control, reference mapping, and mutation calling for pathogens including HIV, TB, SARS-CoV-2, and cancer. It serves assay and instrument manufacturers, laboratories, pharmaceutical companies, clinical trial organizations, and research institutions.
- Who are Hyrax Biosciences (Pty) Ltd's investors?
- Hyrax Biosciences (Pty) Ltd's investors include Asia Africa Investment & Consulting (AAIC).